Page 1 of Clinical Trials for Drug melphalan, 515 Total Matches
- 1RecruitingLast Updated: November 15, 2010Condition(s): Multiple Myeloma; Auto Stem Cell Transplant
- 2TerminatedLast Updated: March 30, 2009Condition(s): Multiple Myeloma
- 3CompletedLast Updated: March 8, 2012Condition(s): Drug/Agent Toxicity by Tissue/Organ; Mucositis; Multiple Myeloma and Plasma Cell Neoplasm
- 4Active, not recruitingLast Updated: May 9, 2009Condition(s): Drug/Agent Toxicity by Tissue/Organ; Multiple Myeloma and Plasma Cell Neoplasm
- 5RecruitingLast Updated: January 11, 2012Condition(s): Central Nervous System Embryonal Tumor; Germ Cell Tumors
- 6Active, not recruitingLast Updated: November 1, 2011Condition(s): Multiple Myeloma
- 7CompletedLast Updated: August 30, 2011Condition(s): Multiple Myeloma; Plasma Cell Neoplasm
- 8CompletedLast Updated: July 9, 2009Condition(s): Leukemia; Myelodysplastic Syndrome; Non-Hodgkin's Lymphoma; Allogeneic Marrow Transplant
- 9CompletedLast Updated: December 27, 2010Condition(s): Neoplasms
- 10RecruitingLast Updated: January 31, 2012Condition(s): Multiple Myeloma
- 11RecruitingLenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple MyelomaLast Updated: March 30, 2012Condition(s): Multiple Myeloma
- 12RecruitingLast Updated: May 15, 2012Condition(s): Multiple Myeloma
- 13Active, not recruitingLast Updated: May 10, 2012Condition(s): Newly Diagnosed Multiple Myeloma
- 14Active, not recruitingLast Updated: August 31, 2009Condition(s): Multiple Sclerosis
- 15RecruitingLast Updated: June 2, 2011Condition(s): Metabolic Disorders; Hematologic, Immune, or Bone Marrow Disorders; Hemoglobinopathies
- 16Active, not recruitingLast Updated: February 6, 2009Condition(s): Leukemia
- 17Not yet recruitingLast Updated: March 7, 2012Condition(s): Multiple Myeloma
- 18TerminatedLast Updated: January 26, 2012Condition(s): Ovarian Cancer
- 19RecruitingLast Updated: November 22, 2011Condition(s): Melanoma
- 20RecruitingLast Updated: January 11, 2012Condition(s): Brain and Central Nervous System Tumors
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+melphalan
